
Overview
As a medical oncologist and hematologist, I treat patients with common adult solid and hematologic cancers. My passion for cancer treatment is deeply rooted back to my childhood when I witnessed loved ones suffering from this devastating disease. As such, I share with patients and their families the feeling of desperation, pain and stress. In my view, cancer treatment is not only a medicine but also an art, as a physician needs to be sensitive to both the patient's physical, and emotional needs to keep their hope for getting better alive. I have particular interests in gastrointestinal malignancies, like esophageal, stomach, small bowel, colon, pancreatic, biliary and liver cancer. I provide my patients with evidence-based and the most advanced treatment options, including participating in clinical trial opportunities.
Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Prostate Cancer, and Thrombocytopenia.
His clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
216 Ashville Ave, Cary, NC 27518
Additional Areas of Focus
Dr. Wang has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of North Carolina At Chapel Hill
Natalie Grover is an Oncologist and a Hematologist in Chapel Hill, North Carolina. Dr. Grover is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Grover is currently accepting new patients.
Duke Blood Cancer Center
I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists. Dr. Stefanovic is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Waldenstrom Macroglobulinemia, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
Rex Hospital Inc
Robert Wehbie is a Hematologist Oncology specialist and an Infectious Disease provider in Raleigh, North Carolina. Dr. Wehbie is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Familial Pancreatic Cancer, Acute Mountain Sickness, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Wehbie is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Colorectal CancerDr. Wang isDistinguished. Learn about Familial Colorectal Cancer.
- Advanced
- Antiphospholipid SyndromeDr. Wang isAdvanced. Learn about Antiphospholipid Syndrome.
- Childhood Iron Deficiency Anemia
- Colorectal CancerDr. Wang isAdvanced. Learn about Colorectal Cancer.
- Essential ThrombocythemiaDr. Wang isAdvanced. Learn about Essential Thrombocythemia.
- Familial Prostate CancerDr. Wang isAdvanced. Learn about Familial Prostate Cancer.
- Iron Deficiency AnemiaDr. Wang isAdvanced. Learn about Iron Deficiency Anemia.
- Experienced
- Acute Mountain SicknessDr. Wang isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Wang isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Wang isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Wang isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Wang isExperienced. Learn about Alveolar Soft Part Sarcoma.

